Revelant, Germain published the artcileExploring S1 plasticity and probing S1′ subsite of mammalian aminopeptidase N/CD13 with highly potent and selective aminobenzosuberone inhibitors, Safety of 1-Methylpyrazole, the publication is Bioorganic & Medicinal Chemistry (2015), 23(13), 3192-3207, database is CAplus and MEDLINE.
In order to probe the S1 and S1′ mammalian aminopeptidase N subsites, racemic 1- or 4-substituted 7-aminobenzocyclohepten-6-ones, e.g. I [R = Br, Cl, Ph, etc.] were synthesized and evaluated for their ability to inhibit mammalian aminopeptidase N. The authors focused on improving the physicochem. and ADME properties of this series by targeting lipophilicity and LELP score. Some 4-heteroaryl substituted analogs displayed reduced lipophilicity and enhanced inhibition potency with Ki values in the nanomolar range.
Bioorganic & Medicinal Chemistry published new progress about 930-36-9. 930-36-9 belongs to pyrazoles-derivatives, auxiliary class Pyrazole, name is 1-Methylpyrazole, and the molecular formula is C4H6N2, Safety of 1-Methylpyrazole.
Referemce:
https://en.wikipedia.org/wiki/Pyrazole,
Pyrazoles – an overview | ScienceDirect Topics